| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension
|
Lee, Jang Hoon
|
|
2016
|
38 |
6 |
p. 1485-1497
13 p.
|
artikel
|
| 2 |
A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
|
Collatz, Ansel
|
|
2016
|
38 |
6 |
p. 1263-1271.e9
1.270999998738E12 p.
|
artikel
|
| 3 |
Bioavailability of Methadone After Sleeve Gastrectomy: A Planned Case Observation
|
Strømmen, Magnus
|
|
2016
|
38 |
6 |
p. 1532-1536
5 p.
|
artikel
|
| 4 |
Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG
|
Rydén, Lars
|
|
2016
|
38 |
6 |
p. 1279-1287
9 p.
|
artikel
|
| 5 |
Clinical Utility of Basophil CD203c as a Biomarker for Predicting the Timing of Hypersensitivity Reaction in Carboplatin Rechallenge: Three Case Reports
|
Iwamoto, Takuya
|
|
2016
|
38 |
6 |
p. 1537-1541
5 p.
|
artikel
|
| 6 |
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial
|
Pinckney, Ashley
|
|
2016
|
38 |
6 |
p. 1327-1339
13 p.
|
artikel
|
| 7 |
Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data
|
Trautmann, Michael E.
|
|
2016
|
38 |
6 |
p. 1464-1473
10 p.
|
artikel
|
| 8 |
Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy
|
Graham, Christopher N.
|
|
2016
|
38 |
6 |
p. 1376-1391
16 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2016
|
38 |
6 |
p. A2-
1 p.
|
artikel
|
| 10 |
Efficacy and Safety Profile of Anti–tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn’s Disease: A Network Meta-analysis of Indirect Comparisons
|
Miligkos, Michael
|
|
2016
|
38 |
6 |
p. 1342-1358.e6
1.357998659E9 p.
|
artikel
|
| 11 |
Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study
|
Sanga, Panna
|
|
2016
|
38 |
6 |
p. 1435-1450
16 p.
|
artikel
|
| 12 |
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus
|
Schernthaner, Guntram
|
|
2016
|
38 |
6 |
p. 1288-1298
11 p.
|
artikel
|
| 13 |
Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy
|
Bendixen, Roxanna M.
|
|
2016
|
38 |
6 |
p. 1474-1484.e2
146927 p.
|
artikel
|
| 14 |
Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes
|
Ryan, John G.
|
|
2016
|
38 |
6 |
p. 1274-1278
5 p.
|
artikel
|
| 15 |
Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases
|
Harnett, James
|
|
2016
|
38 |
6 |
p. 1451-1463
13 p.
|
artikel
|
| 16 |
Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012
|
Weng, Wayne
|
|
2016
|
38 |
6 |
p. 1314-1326
13 p.
|
artikel
|
| 17 |
Lorcaserin in Obese and Overweight Patients Taking Prohibited Serotonergic Agents: A Retrospective Analysis
|
Nguyen, Charles T.
|
|
2016
|
38 |
6 |
p. 1498-1509
12 p.
|
artikel
|
| 18 |
Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012–2013)
|
Zalacain, Magdalena
|
|
2016
|
38 |
6 |
p. 1510-1521
12 p.
|
artikel
|
| 19 |
Rescue Sedation With Intranasal Dexmedetomidine for Pediatric Ophthalmic Examination After Chloral Hydrate Failure: A Randomized, Controlled Trial
|
Gan, Xiaoliang
|
|
2016
|
38 |
6 |
p. 1522-1529
8 p.
|
artikel
|
| 20 |
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
|
Kohler, Sven
|
|
2016
|
38 |
6 |
p. 1299-1313
15 p.
|
artikel
|
| 21 |
Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study
|
Chen, Christopher B.
|
|
2016
|
38 |
6 |
p. 1392-1400
9 p.
|
artikel
|
| 22 |
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects
|
Bhattacharya, Indranil
|
|
2016
|
38 |
6 |
p. 1401-1416
16 p.
|
artikel
|
| 23 |
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus
|
Cohen, Stanley
|
|
2016
|
38 |
6 |
p. 1417-1434.e2
141984 p.
|
artikel
|
| 24 |
Some Reflections on Diabetes Mellitus
|
Shader, Richard I.
|
|
2016
|
38 |
6 |
p. 1259-1261
3 p.
|
artikel
|
| 25 |
Table of Contents
|
|
|
2016
|
38 |
6 |
p. A4-A6
nvt p.
|
artikel
|
| 26 |
Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data
|
Sugiyama, Naonobu
|
|
2016
|
38 |
6 |
p. 1359-1375.e1
12392 p.
|
artikel
|
Tijdschrift beschrijving